相关实验视频

Updated: Sep 18, 2025

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

Published on: June 17, 2025

免疫疗法用于pemphigus和球状皮虫

Chuqiao Xu¹, Yiting Shen¹, Qijun Wang¹

¹Department of Dermatology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Current opinion in immunology

|June 24, 2025

概括

菌体和球状菌体 (BP) 是一种自身免疫性泡性疾病,用免疫疗法治疗. 最近的进展包括针对性疗法,如用于合体的rituximab和用于BP的dupilumab,改善了患者的治疗结果.

科学领域:

免疫学免疫学免疫学
皮肤病学皮肤病学
自免疫性疾病自免疫性疾病

背景情况:

流体和流体流体 (BP) 是不同的自身免疫性流体疾病 (AIBD).
皮体包括内皮层泡 (抗脱皮体抗体),而BP则具有亚皮层泡 (抗皮层-皮层结合抗体).
传统的治疗方法依赖于全身葡萄皮质激素和免疫抑制剂.

研究的目的:

审查最近免疫治疗虫和BP的进展.
讨论新型免疫向疗法的临床应用.
突出这些主要AIBDs的不断变化的治疗环境.

主要方法:

最近临床研究和试验的文献综述.
免疫疗法机制和疗效的分析.
综合有关新生物药物和向治疗的数据.

主要成果:

利图西马布 (抗CD20) 是有效的作为一线治疗pemphigus.
杜皮卢马布 (抗IL-4受体) 对耐火性高血压有希望,与2型炎症有关.
针对这两种疾病,正在研究各种免疫向疗法.

结论:

免疫疗法在治疗尾虫和高血压方面取得了重大进展.
向生物制剂为耐火性疾病患者提供了新的希望.
对免疫向疗法的持续研究对于优化AIBD治疗至关重要.

更多相关视频

Granulocyte-dependent Autoantibody-induced Skin Blistering

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on: May 17, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...